Watchlist Price Alert

4D Molecular Therapeutics... (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

4.17

-0.20 (-4.58%)

At close: Jun 17, 2025, 2:06 PM

4D Molecular Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	149.34M	249.11M	218.64M	315.43M	276.73M	49.65M	91.76M	23.85M
Short-Term Investments	275.54M	39.12M	161.2M	94.78M	n/a	n/a	n/a	n/a
Long-Term Investments	80.58M	10.95M	4.91M	67.65M	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.26M	684K	1.08M	-58.55M	602K	677K	429K	105K
Receivables	n/a	n/a	n/a	47K	1.49M	978K	1.12M	321K
Inventory	n/a	n/a	-5.79M	-8.5M	n/a	n/a	n/a	n/a
Other Current Assets	10.05M	8.36M	6.96M	n/a	4.44M	n/a	n/a	n/a
Total Current Assets	434.93M	296.59M	220.51M	315.43M	282.66M	52.51M	94.07M	24.5M
Property-Plant & Equipment	40.61M	31.66M	35.35M	28.95M	5.07M	5.05M	2.47M	2.72M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	125.45M	43.3M	41.34M	38.06M	5.67M	5.73M	2.9M	2.82M
Total Assets	560.38M	339.89M	261.85M	353.49M	288.33M	58.23M	96.97M	27.32M
Account Payables	4.39M	3.52M	3.32M	4.76M	1.79M	1.74M	954K	460K
Deferred Revenue	257K	273K	884K	2.6M	6.59M	5.86M	4.91M	4.38M
Short-Term Debt	5.64M	n/a	2.65M	1.23M	n/a	n/a	n/a	n/a
Other Current Liabilities	18.87M	3.87M	1.05M	5.04M	n/a	n/a	n/a	279K
Total Current Liabilities	29.15M	18.95M	15.73M	16.34M	16.74M	12.96M	8.05M	5.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	603K	617K	233K	334K	1.97M	104.65M	103.43M	18.81M
Total Long-Term Liabilities	20.63M	13.11M	14.78M	18.04M	15.2M	118.25M	116.5M	41M
Total Liabilities	49.78M	32.06M	30.51M	560.48M	31.94M	131.2M	124.56M	46.91M
Total Debt	24.61M	14.67M	16.12M	16.45M	n/a	n/a	n/a	n/a
Common Stock	5K	4K	3K	3K	3K	1K	1K	1K
Retained Earnings	-576.2M	-415.33M	-314.49M	-207M	-135.68M	-79.03M	-30.03M	-20.48M
Comprehensive Income	n/a	16K	-1.2M	-423K	-288.33M	-102.98M	-102.98M	-18.51M
Shareholders Equity	510.61M	307.83M	-314.49M	-207M	256.39M	-72.97M	-27.59M	-19.59M
Total Investments	356.12M	50.08M	166.11M	162.43M	n/a	n/a	n/a	n/a